Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
Conclusions
Colchicine use was associated with a reduced risk of a CV event among patients with gout.
Source: Annals of the Rheumatic Diseases - Category: Rheumatology Authors: Solomon, D. H., Liu, C.-C., Kuo, I.-H., Zak, A., Kim, S. C. Tags: Genetics, Degenerative joint disease, Musculoskeletal syndromes, Epidemiology Clinical and epidemiological research Source Type: research
More News: Cardiology | Cardiovascular | Colchicine | Colcrys | Databases & Libraries | Electronic Medical Records (EMR) | Epidemiology | Genetics | Gout | Heart | Heart Attack | Ischemic Stroke | Medicare | Rheumatology | Stroke | Study